The use of molnupiravir in COVID-19 cases aims to reduce the pressure on hospitals, in turn reducing the risk of patients developing more severe symptoms of the virus. More: EMA receive marketing authorisation application for molnupiravir Source: News
read morePfizer says former employee stole trade secrets on megablockbuster COVID-19 vaccine esagonowsky Wed, 11/24/2021 – 11:38 More: Pfizer says former employee stole trade secrets on megablockbuster COVID-19 vaccine Source: fierce
read moreBushu expects to double the volume of Amgen drugs it makes under new Asia CMO pact fkansteiner Wed, 11/24/2021 – 10:38 More: Bushu expects to double the volume of Amgen drugs it makes under new Asia CMO pact Source: fierce
read moreSun Pharma loses bid to drop Ranbaxy antitrust case; jury trail set for January kdunleavy Wed, 11/24/2021 – 10:25 More: Sun Pharma loses bid to drop Ranbaxy antitrust case; jury trail set for January Source: fierce
read moreTakeda’s post-transplant CMV drug Livtencity, shouldering $800M in sales expectations, scores FDA nod aliu Wed, 11/24/2021 – 10:19 More: Takeda's post-transplant CMV drug Livtencity, shouldering 0M in sales expectations, scores FDA nod Source: fierce
read moreAfter Biden admin failed to submit FDA chief paperwork on time, hopes for a speedy confirmation vote likely dashed: report fkansteiner Wed, 11/24/2021 – 09:04 More: After Biden admin failed to submit FDA chief paperwork on time, hopes for a
read more© 1994 - 2026 B.M. Pharmaceuticals